Literature DB >> 9120010

Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis.

P Goluszko1, S L Moseley, L D Truong, A Kaul, J R Williford, R Selvarangan, S Nowicki, B Nowicki.   

Abstract

Escherichia coli that express Dr fimbriae and related adhesins recognize the common receptor decay accelerating factor. E. coli strains that express adhesins of the Dr family were postulated to be associated with cystitis (30-50%), pregnancy-associated pyelonephritis (30%), and chronic diarrhea (50%). In this study, we investigated the hypothesis that E. coli renal interstitial binding mediated by the Dr adhesin may be important for the development of chronic pyelonephritis. An insertional dra mutant, E. coli DR14, of the clinical E. coli isolate IH11128 bearing Dr fimbriae, was constructed and used to characterize persistence of infection and interstitial tropism in an experimental model of ascending pyelonephritis. Quantitative cultures of kidney homogenates indicated that Dr hemagglutinin positive (Dr+) E. coli IH11128 established a 1-yr colonization of renal tissue. In the Dr hemagglutinin negative (Dr-) group, 50% of animals cleared infection within 20 wk and 100% between 32 to 52 wk. Dr+ E. coli colonized the renal interstitium. Significant histological changes corresponding to tubulointerstitial nephritis including interstitial inflammation, fibrosis, and tubular atrophy were found in the kidney tissue of the Dr+ but not the Dr- group. A substantial amount of fimbrial antigen was detected in the parenchymal regions affected by interstitial inflammation and fibrosis. The obtained results are consistent with the hypothesis that mutation within the dra region, affecting E. coli binding to tubular basement membranes, prevented renal interstitial tropism and the development of the changes characteristically seen in tubulointerstitial nephritis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9120010      PMCID: PMC507986          DOI: 10.1172/JCI119329

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Molecular cloning of the Escherichia coli O75X adhesin.

Authors:  B Nowicki; J P Barrish; T Korhonen; R A Hull; S I Hull
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

2.  Transcriptional organization of the F1845 fimbrial adhesin determinant of Escherichia coli.

Authors:  S S Bilge; J M Apostol; K J Fullner; S L Moseley
Journal:  Mol Microbiol       Date:  1993-03       Impact factor: 3.501

3.  Prevention of renal scarring from pyelonephritis in nonhuman primates by vaccination with a synthetic Escherichia coli serotype O8 oligosaccharide-protein conjugate.

Authors:  J A Roberts; M B Kaack; G Baskin; S B Svenson
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

4.  Stimulation of human polymorphonuclear leukocyte oxidative metabolism by type 1 pili from Escherichia coli.

Authors:  M B Goetz; F J Silverblatt
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

5.  Pathways of urinary backflow in obstructive uropathy. Demonstration by pigmented gelatin injection and Tamm-Horsfall uromucoprotein markers.

Authors:  B S Bhagavan; R E Wenk; D Dutta
Journal:  Hum Pathol       Date:  1979-11       Impact factor: 3.466

6.  Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin.

Authors:  L Hagberg; I Engberg; R Freter; J Lam; S Olling; C Svanborg Edén
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

7.  Focal and segmental glomerular sclerosis in reflux nephropathy.

Authors:  D B Bhathena; J H Weiss; N H Holland; R G McMorrow; J J Curtis; B A Lucas; R G Luke
Journal:  Am J Med       Date:  1980-06       Impact factor: 4.965

8.  Localization of binding sites for purified Escherichia coli P fimbriae in the human kidney.

Authors:  T K Korhonen; R Virkola; H Holthöfer
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

9.  Codistribution of collagen types IV and AB2 in basement membranes and mesangium of the kidney. an immunoferritin study of ultrathin frozen sections.

Authors:  F J Roll; J A Madri; J Albert; H Furthmayr
Journal:  J Cell Biol       Date:  1980-06       Impact factor: 10.539

10.  Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction.

Authors:  B Nowicki; A Hart; K E Coyne; D M Lublin; S Nowicki
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  61 in total

1.  The flagellar hook protein, FlgE, of Salmonella enterica serovar typhimurium is posttranscriptionally regulated in response to the stage of flagellar assembly.

Authors:  H R Bonifield; S Yamaguchi; K T Hughes
Journal:  J Bacteriol       Date:  2000-07       Impact factor: 3.490

2.  Characterization of the Escherichia coli AF/R1 pilus operon: novel genes necessary for transcriptional regulation and for pilus-mediated adherence.

Authors:  J R Cantey; R K Blake; J R Williford; S L Moseley
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Inverse relationship between severity of experimental pyelonephritis and nitric oxide production in C3H/HeJ mice.

Authors:  B Nowicki; J Singhal; L Fang; S Nowicki; C Yallampalli
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

4.  Flagellar phase variation in Salmonella enterica is mediated by a posttranscriptional control mechanism.

Authors:  Heather R Bonifield; Kelly T Hughes
Journal:  J Bacteriol       Date:  2003-06       Impact factor: 3.490

Review 5.  Host-pathogen interactions in urinary tract infection.

Authors:  Greta R Nielubowicz; Harry L T Mobley
Journal:  Nat Rev Urol       Date:  2010-07-20       Impact factor: 14.432

6.  Prophylactic herbal therapy prevents experimental ascending urinary tract infection in mice.

Authors:  Yan-Qing Tong; Min Sun; Ying Chi
Journal:  Chin J Integr Med       Date:  2016-07-19       Impact factor: 1.978

7.  Hydrophilic domain II of Escherichia coli Dr fimbriae facilitates cell invasion.

Authors:  Margaret Das; Audrey Hart-Van Tassell; Petri T Urvil; Susan Lea; David Pettigrew; K L Anderson; Alfred Samet; Jozef Kur; Steve Matthews; Stella Nowicki; Vsevolod Popov; Pawel Goluszko; Bogdan J Nowicki
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

8.  Vaccination with purified Dr Fimbriae reduces mortality associated with chronic urinary tract infection due to Escherichia coli bearing Dr adhesin.

Authors:  Pawel Goluszko; Elzbieta Goluszko; Bogdan Nowicki; Stella Nowicki; Vsevolod Popov; Hui-Qun Wang
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 9.  Urinary tract infections: new insights into a common problem.

Authors:  R Kucheria; P Dasgupta; S H Sacks; M S Khan; N S Sheerin
Journal:  Postgrad Med J       Date:  2005-02       Impact factor: 2.401

10.  Translation inhibition of the Salmonella fliC gene by the fliC 5' untranslated region, fliC coding sequences, and FlgM.

Authors:  Valentina Rosu; Fabienne F V Chevance; Joyce E Karlinsey; Takanori Hirano; Kelly T Hughes
Journal:  J Bacteriol       Date:  2006-06       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.